当前位置: X-MOL 学术Biol. Reprod. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ephrin and Eph Receptor Signaling in Female Reproductive Physiology and Pathology.
Biology of Reproduction ( IF 3.6 ) Pub Date : 2020-09-17 , DOI: 10.1093/biolre/ioaa171
Enoch Appiah Adu-Gyamfi 1, 2 , Armin Czika 1, 2 , Tai-Hang Liu 2 , Philip Narteh Gorleku 3 , Linda Ahenkorah Fondjo 4 , Francis Tanam Djankpa 5 , Yu-Bin Ding 1, 2 , Ying-Xiong Wang 1, 2
Affiliation  

Ephrins are ligands of Eph receptors (Ephs); both of which are sorted into two classes, A and B. There are five types of ephrin-As (ephrin-A1–5) and three types of ephrin-Bs (ephrin-B1–3). Also, there are 10 types of EphAs (EphA1–10) and six types of EphBs (EphB1–6). Binding of ephrins to the Eph receptors activates signaling cascades that regulate several biological processes such as cellular proliferation, differentiation, migration, angiogenesis, and vascular remodeling. Clarification of their roles in the female reproductive system is crucial to understanding the physiology and pathology of this system. Such knowledge will also create awareness regarding the importance of these molecules in diagnostic, prognostic, and therapeutic medicine. Hence, we have discussed the involvement of these molecules in the physiological and pathological events that occur within the female reproductive system. The evidence so far suggests that the ephrins and the Eph receptors modulate folliculogenesis, ovulation, embryo transport, implantation, and placentation. Abnormal expression of some of these molecules is associated with polycystic ovarian syndrome, ovarian cancer, tubal pregnancy, endometrial cancer, uterine leiomyoma (fibroids), cervical cancer, and preeclampsia, suggesting the need to utilize these molecules in the clinical setting. To enhance a quick development of this gradually emerging field in female reproductive medicine, we have highlighted some “gaps in knowledge” that need prospective investigation.

中文翻译:

女性生殖生理学和病理学中的 Ephrin 和 Eph 受体信号传导。

Ephrin 是 Eph 受体 (Ephs) 的配体;两者都分为两类,A 和 B。有五种类型的 ephrin-As (ephrin-A1-5) 和三种类型的 ephrin-Bs (ephrin-B1-3)。此外,还有 10 种 EphA (EphA1-10) 和 6 种 EphB (EphB1-6)。肝配蛋白与 Eph 受体的结合激活了信号级联反应,这些级联反应调节多种生物过程,例如细胞增殖、分化、迁移、血管生成和血管重塑。澄清它们在女性生殖系统中的作用对于了解该系统的生理学和病理学至关重要。这些知识还将使人们意识到这些分子在诊断、预后和治疗医学中的重要性。因此,我们已经讨论了这些分子在女性生殖系统内发生的生理和病理事件中的作用。迄今为止的证据表明,肝配蛋白和 Eph 受体调节卵泡发生、排卵、胚胎运输、植入和胎盘形成。其中一些分子的异常表达与多囊卵巢综合征、卵巢癌、输卵管妊娠、子宫内膜癌、子宫平滑肌瘤(肌瘤)、宫颈癌和先兆子痫有关,这表明需要在临床环境中使用这些分子。为了促进这一逐渐兴起的女性生殖医学领域的快速发展,我们强调了一些需要前瞻性调查的“知识空白”。迄今为止的证据表明,肝配蛋白和 Eph 受体调节卵泡发生、排卵、胚胎运输、植入和胎盘形成。其中一些分子的异常表达与多囊卵巢综合征、卵巢癌、输卵管妊娠、子宫内膜癌、子宫平滑肌瘤(肌瘤)、宫颈癌和先兆子痫有关,这表明需要在临床环境中使用这些分子。为了促进这一逐渐兴起的女性生殖医学领域的快速发展,我们强调了一些需要前瞻性调查的“知识空白”。迄今为止的证据表明,肝配蛋白和 Eph 受体调节卵泡发生、排卵、胚胎运输、植入和胎盘形成。其中一些分子的异常表达与多囊卵巢综合征、卵巢癌、输卵管妊娠、子宫内膜癌、子宫平滑肌瘤(肌瘤)、宫颈癌和先兆子痫有关,这表明需要在临床环境中使用这些分子。为了促进这一逐渐兴起的女性生殖医学领域的快速发展,我们强调了一些需要前瞻性调查的“知识空白”。子宫内膜癌、子宫平滑肌瘤(肌瘤)、宫颈癌和先兆子痫,这表明需要在临床环境中使用这些分子。为了促进这一逐渐兴起的女性生殖医学领域的快速发展,我们强调了一些需要前瞻性调查的“知识空白”。子宫内膜癌、子宫平滑肌瘤(肌瘤)、宫颈癌和先兆子痫,这表明需要在临床环境中使用这些分子。为了促进这一逐渐兴起的女性生殖医学领域的快速发展,我们强调了一些需要前瞻性调查的“知识空白”。
更新日期:2020-09-17
down
wechat
bug